申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20180133198A1
公开(公告)日:2018-05-17
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.